Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts.
During clinical trials some candidates respond better to certain treatments and AI can be used to identify the cellular traits that makes the treatment work. The work is a collaboration by Nation Cancer Institute and many prominent hospitals and has found success. But still in research phase
Genome sequencing and Data sets "National Cancer Institute is building a TCGA cancer genomics databases to probe the basic biology of cancer, that has genomically profiled more than 11,000 samples of tumor tissue and matched samples of normal tissue, to gain an understanding of cancer in molecular detail."
Identifying the right candidates have achieved promising results including saving lives of several patients